COMMUNIQUÉS West-GlobeNewswire

LA Limited Addition Drumline, Breast Cancer Prevention Advocates Join Actress Dionne Lea and Renowned Breast Cancer Surgeon Dr. Kristi Funk to Rally in View Park to “Beat” Breast Cancer
21/09/2026
LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Breast cancer prevention advocates, nutrition experts, and community members will gather for a special Let’s Beat Breast Cancer rally from 1 to 3 p.m. on Sunday, Sept. 27 [...]
Le KFSH figure dans le classement 2027 des meilleurs hôpitaux spécialisés au monde établi par Newsweek
21/09/2026
RIYAD, Arabie saoudite, 21 sept. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) consolide sa position parmi les établissements de santé de référence à l’échelle mondiale en [...]
TestoPrime 2026: Announces Updated TestoPrime Gold Supplement Natural Testosterone Booster For Men for Men’s Over 40.
21/09/2026
TestoPrime announces updated TestoPrime Gold and ingredients information, offering insights into a natural testosterone booster Supplement for men over 40 and men’s wellness. New York, Sept. 21, 2026 (GLOBE NEWSWIRE [...]
Nyxoah Annonce une Transition au Poste de Chief Financial Officer
21/09/2026
INFORMATIONS RÉGLEMENTÉES INFORMATIONS PRIVILÉGIÉES Nyxoah Annonce une Transition au Poste de Chief Financial Officer Loïc Moreau, President International et ancien CFO de Nyxoah, assurera l’intérim au poste de CFO La [...]
Nyxoah Announces Chief Financial Officer Transition
21/09/2026
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Chief Financial Officer Transition Loïc Moreau, Nyxoah’s President International and former CFO, to serve as interim CFO Company reaffirms full year 2026 [...]
Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
21/09/2026
MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced the closing of its previously announced indirect acquisition of M3 Wellness, a [...]
Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
21/09/2026
VANCOUVER, BC and BOSTON, MA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
21/09/2026
RADNOR, Pa., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
21/09/2026
Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026 Chris Rabbat succédera à Fabio Cataldi au poste de Directeur médical (« Chief Medical Officer » ou « CMO ») ; [...]
Abivax Presents Business Updates and First Half 2026 Financial Results
21/09/2026
Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly appointed Chief Technical Officer to advance commercial supply readiness [...]
CVRx Appoints John Landry as Chief Financial Officer
21/09/2026
Landry Brings Two Decades of Medtech and Public Company Finance Experience MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on [...]
Let’s Beat Breast Cancer Give-A-Thon Brings Celebrities, Breast Cancer Experts, and Survivors Together to Share Prevention Information and Inspire Action
21/09/2026
Virtual event airs live on Tuesday, Sept. 22, 2026, at 8 p.m. ET on YouTube WASHINGTON, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Breast cancer experts, celebrities, advocates, and survivors will come together Tuesday evening [...]
Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update
21/09/2026
Jemperli global net sales of $644 million (£480 million) for the six months ended June 30, 2026, representing 34% year-over-year growth Positive interim results from the pivotal AZUR-1 trial of Jemperli in untreated [...]
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
21/09/2026
PONTE VEDRA, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan [...]
TOMI Environmental Solutions Announces Mutual Termination of Merger Agreement with Carbonium Core
21/09/2026
FREDERICK, Md., Sept. 21, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, and Carbonium Core, Inc. (“Carbonium”), [...]
Onco360® is a participating specialty pharmacy in the ZENBEXUS™ (iberdomide) limited dispense network
21/09/2026
LOUISVILLE, Ky., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a participating pharmacy by Bristol-Myers Squibb for ZENBEXUS™ (iberdomide), [...]
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
21/09/2026
CEO Michael Halstead to participate in a fireside chat on September 23, 2026 at 9:00 a.m. EDT NEW YORK and TORONTO, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus [...]
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
21/09/2026
By continuously delivering medicine into the eye through the Contivue refillable implant, Susvimo is the first and only continuous delivery treatment that offers an alternative to standard-of-care eye injections for [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2026
21/09/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]

Pages